{"slideshow_credits": null, "snippet": "The Swiss drug companies were ordered to pay a total of $250 million for trying to keep doctors from prescribing a relatively inexpensive eye treatment.", "abstract": "Italian antitrust authorities say they fined Swiss drug companies Novartis and Roche Holdings total of $250 million for colluding to keep doctors from prescribing relatively inexpensive eye treatment Avastin in favor of more expensive drug.", "section_name": "Business Day", "print_page": "2", "document_type": "article", "byline": {"person": [{"firstname": "David", "role": "reported", "lastname": "JOLLY", "rank": 1, "organization": ""}], "original": "By DAVID JOLLY", "contributor": ""}, "web_url": "http://www.nytimes.com/2014/03/06/business/international/italy-fines-novartis-and-roche-in-collusion-case.html", "lead_paragraph": "The Swiss drug companies were ordered to pay a total of $250 million for trying to keep doctors from prescribing a relatively inexpensive eye treatment.", "headline": {"main": "Italy Fines Novartis and Roche in Collusion Case", "print_headline": "2 Pharmaceutical Makers Fined for Undermining a Rival\u2019s Drug"}, "_id": "5317199638f0d86fea64d371", "word_count": "820", "multimedia": [], "pub_date": "2014-03-06T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Italy", "name": "glocations", "is_major": "Y", "rank": "5"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Antitrust Laws and Competition Issues", "name": "subject", "is_major": "N", "rank": "6"}, {"value": "Novartis AG", "name": "organizations", "is_major": "Y", "rank": "3"}, {"value": "Avastin (Drug)", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Roche Holding A G", "name": "organizations", "is_major": "Y", "rank": "4"}], "blog": [], "subsection_name": "International Business", "type_of_material": "News"}